Second, we found that gefitinib was effective in reducing pulmonary fibrosis in mice, which might be associated with the HMGB1/NOXs-ROS/EGFR-MAPKs-AP-1/NF-κB signal (Figure 10). The gene discussed is HMGB1; the disease is pulmonary fibrosis.